A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines 
the risk for mood disorders

Barden, N.; Harvey, M.; Gagne, B.; Raymond, C.; Labbe, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders

MPS-Authors

/persons/resource/persons80450

Müller-Myhsok, B.
AG Müller-Myhsok, Bertram, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80272

Binder, E.
AG Binder, Elisabeth, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Barden, N., Harvey, M., Gagne, B., Raymond, C., Labbe, M., Müller-Myhsok, B., et al. (2005). A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 138B(1), 82-82.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9A1C-8

Abstract

There is no abstract available